Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Praxis Precision Medicines announced that its investigational drug Elsunersen demonstrated good tolerability in clinical trials.

Praxis Precision Medicines announced that its investigational drug Elsunersen demonstrated good tolerability in clinical trials.

老虎证券老虎证券2026/04/06 12:10
Show original
Data show that within the dose escalation range up to 8 milligrams, no serious adverse events related to the drug were observed. This result further supports the safety profile of the candidate drug.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

EUR/USD: ECB hawks lag Fed – ING

FXStreet•2026/11/13 09:48
EUR/USD: ECB hawks lag Fed – ING

Goldman Sachs: Applied Materials (AMAT.US) Posts Solid Q4 Results, DRAM and Advanced Packaging to Drive Accelerated Growth by 2027

Goldman Sachs maintains its "Buy" rating on Applied Materials but lowers its 12-month target price from $670 to $580.

智通财经•2026/11/13 09:18
Goldman Sachs: Applied Materials (AMAT.US) Posts Solid Q4 Results, DRAM and Advanced Packaging to Drive Accelerated Growth by 2027